Shenzhen YHLO Biotech Co Ltd
SSE:688575

Watchlist Manager
Shenzhen YHLO Biotech Co Ltd Logo
Shenzhen YHLO Biotech Co Ltd
SSE:688575
Watchlist
Price: 24.29 CNY 3.05% Market Closed
Updated: Jun 1, 2024

Cash Flow Statement

Cash Flow Statement
Shenzhen YHLO Biotech Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Cash Taxes Paid
(53)
(61)
(85)
(76)
(80)
(71)
(131)
(177)
(234)
(264)
(252)
(205)
(146)
(122)
Change in Working Capital
(280)
(304)
(341)
(344)
(335)
(403)
(658)
(741)
(844)
(892)
(769)
(761)
(695)
(632)
Cash from Operating Activities
282
N/A
269
-5%
230
-14%
253
+10%
260
+3%
813
+213%
816
+0%
933
+14%
1 583
+70%
663
-58%
419
-37%
292
-30%
(73)
N/A
359
N/A
Investing Cash Flow
Capital Expenditures
(189)
(252)
(256)
(299)
(373)
(312)
(436)
(521)
(565)
(596)
(633)
(624)
(663)
(697)
Other Items
22
0
1
(78)
(88)
(145)
(309)
(228)
(304)
(258)
(23)
(54)
28
80
Cash from Investing Activities
(168)
N/A
(251)
-49%
(255)
-2%
(377)
-48%
(461)
-22%
(457)
+1%
(745)
-63%
(749)
-1%
(870)
-16%
(854)
+2%
(656)
+23%
(678)
-3%
(635)
+6%
(617)
+3%
Financing Cash Flow
Net Issuance of Debt
38
(8)
(29)
(113)
(81)
(59)
185
96
240
129
295
518
252
298
Cash Paid for Dividends
0
0
(40)
(9)
(11)
(12)
(170)
(170)
(169)
(168)
(253)
(252)
(283)
(283)
Other
(47)
(46)
519
500
539
552
(28)
13
(57)
(65)
(17)
(24)
11
13
Cash from Financing Activities
(9)
N/A
(55)
-519%
484
N/A
411
-15%
448
+9%
481
+7%
(14)
N/A
(62)
-341%
13
N/A
(103)
N/A
25
N/A
243
+867%
(19)
N/A
28
N/A
Change in Cash
Effect of Foreign Exchange Rates
(3)
(2)
(4)
(2)
(1)
0
17
19
10
6
(1)
(4)
4
4
Net Change in Cash
103
N/A
(39)
N/A
455
N/A
285
-37%
245
-14%
837
+242%
75
-91%
141
+88%
737
+424%
(289)
N/A
(213)
+26%
(148)
+30%
(723)
-388%
(226)
+69%
Free Cash Flow
Free Cash Flow
93
N/A
17
-82%
(26)
N/A
(45)
-72%
(113)
-149%
501
N/A
381
-24%
412
+8%
1 018
+147%
66
-93%
(214)
N/A
(333)
-55%
(736)
-121%
(339)
+54%

See Also

Discover More